Cargando…
The role of Interleukin-17A and Interleukin-17E in multiple myeloma patients
BACKGROUND: Tumor growth in multiple myeloma (MM) is regulated by the cytokine networks which are produced by myeloma cells and the microenvironment of the bone marrow. Interleukin-17 (IL-17) is implicated in the increased angiogenesis in the bone marrow of MM. Recent studies reported elevated level...
Autores principales: | Lemancewicz, Dorota, Bolkun, Lukasz, Jablonska, Ewa, Czeczuga-Semeniuk, Ewa, Kostur, Agnieszka, Kloczko, Janusz, Dzieciol, Janusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560674/ https://www.ncbi.nlm.nih.gov/pubmed/22207110 http://dx.doi.org/10.12659/MSM.882204 |
Ejemplares similares
-
BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma
por: Bolkun, L., et al.
Publicado: (2013) -
Secondary acute lymphoblastic leukaemia in a multiple myeloma patient
por: Piszcz, Jaroslaw, et al.
Publicado: (2013) -
The impact of TNF superfamily molecules on overall survival in acute myeloid leukaemia: correlation with biological and clinical features
por: Bolkun, L., et al.
Publicado: (2014) -
High chymotrypsin-like activity in the plasma of patients with newly diagnosed multiple myeloma treated with bortezomib is predictive of a better response and longer PFS
por: Romaniuk, Wioletta, et al.
Publicado: (2018) -
Out of the shadow of interleukin-17A: the role of interleukin-17F and other interleukin-17 family cytokines in spondyloarthritis
por: Yeremenko, Nataliya
Publicado: (2021)